Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise A Knight

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Quality assurance and good laboratory practiceLouise A Knight, Ian A Cree
Anti-Cancer Drugs|September 16, 2005
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assayLouise A Knight, Mark Conroy, Augusta Fernando, et al.
Anti-Cancer Drugs|June 5, 2003
Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA)Pauline A Whitehouse, Louise A Knight, Federica Di Nicolantonio, et al.
Anti-Cancer Drugs|December 8, 2009
The effect of pentamidine on melanoma ex vivoJason Smith, Benjamin J Stewart, Sharon Glaysher, et al.
BMC Cancer|November 25, 2004
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursLouise A Knight, Federica Di Nicolantonio, Pauline Whitehouse, et al.
BMC Cancer|January 30, 2009
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assayLouise A Knight, Christian M Kurbacher, Sharon Glaysher, et al.
Anti-Cancer Drugs|August 31, 2006
Effect of culture conditions on the chemosensitivity of ovarian cancer cell linesAugusta Fernando, Sharon Glaysher, Mark Conroy, et al.
Molecular Cancer Therapeutics|January 7, 2005
The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samplesFederica Di Nicolantonio, Louise A Knight, Pauline A Whitehouse, et al.
Anti-Cancer Drugs|September 8, 2011
The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell culturesKatharine A Parker, Sharon Glaysher, Jeremy Hurren, et al.
Journal of Clinical Pathology|October 7, 2010
The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapyKatharine A Parker, Sharon Glaysher, Marta Polak, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|April 26, 2011
Quality assurance and good laboratory practiceLouise A Knight, Ian A Cree
Anti-Cancer Drugs|September 16, 2005
Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assayLouise A Knight, Mark Conroy, Augusta Fernando, et al.
Anti-Cancer Drugs|June 5, 2003
Heterogeneity of chemosensitivity of colorectal adenocarcinoma determined by a modified ex vivo ATP-tumor chemosensitivity assay (ATP-TCA)Pauline A Whitehouse, Louise A Knight, Federica Di Nicolantonio, et al.
Anti-Cancer Drugs|December 8, 2009
The effect of pentamidine on melanoma ex vivoJason Smith, Benjamin J Stewart, Sharon Glaysher, et al.
BMC Cancer|November 25, 2004
The in vitro effect of gefitinib ('Iressa') alone and in combination with cytotoxic chemotherapy on human solid tumoursLouise A Knight, Federica Di Nicolantonio, Pauline Whitehouse, et al.
BMC Cancer|January 30, 2009
Activity of mevalonate pathway inhibitors against breast and ovarian cancers in the ATP-based tumour chemosensitivity assayLouise A Knight, Christian M Kurbacher, Sharon Glaysher, et al.
Anti-Cancer Drugs|August 31, 2006
Effect of culture conditions on the chemosensitivity of ovarian cancer cell linesAugusta Fernando, Sharon Glaysher, Mark Conroy, et al.
Molecular Cancer Therapeutics|January 7, 2005
The ex vivo characterization of XR5944 (MLN944) against a panel of human clinical tumor samplesFederica Di Nicolantonio, Louise A Knight, Pauline A Whitehouse, et al.
Anti-Cancer Drugs|September 8, 2011
The effect of tricyclic antidepressants on cutaneous melanoma cell lines and primary cell culturesKatharine A Parker, Sharon Glaysher, Jeremy Hurren, et al.
Journal of Clinical Pathology|October 7, 2010
The molecular basis of the chemosensitivity of metastatic cutaneous melanoma to chemotherapyKatharine A Parker, Sharon Glaysher, Marta Polak, et al.
Pageof 2